WuXi Biologics Honored with CDMO Leadership Awards for Ninth Consecutive Year

WuXi Biologics Honored with CDMO Leadership Awards for Ninth Consecutive Year Accessibility StatementSkip Navigation SHANGHAI, March 30, 2026 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has won "Biologics CDMO of the Year" (Large CDMOs) in the 2026 CDMO Leadership Awards. The company has also been recognized for excellence across multiple categories for "Large CDMO Biologic", including "B ...